By Professor Sallie Pearson

Book Chapters

Karanges EA; Litchfield MJ; Mellish L; Pearson S-A, 2021, 'The Australian Pharmaceutical Benefits Scheme (PBS) Dispensing Database', in Springer Series on Epidemiology and Public Health, Springer International Publishing, pp. 255 - 266, http://dx.doi.org/10.1007/978-3-030-51455-6_21

, 2014, 'Coriell Personalized Medicine Collaborative: Exploring the Utility of Personalized Medicine', in Handbook of Personalized Medicine, Jenny Stanford Publishing, pp. 1373 - 1418, http://dx.doi.org/10.1201/b15465-31

Langton JM; Pearson SA, 2013, 'Electronic decision support systems for prescribing: Challenges and perspectives for personalized medicine', in Handbook of Personalized Medicine Advances in Nanotechnology Drug Delivery and Therapy, pp. 1439 - 1472, http://dx.doi.org/10.4032/9789814411202

Gordon J; Rolfe I; Pearson S; Willcock S, 1997, 'Assessment of Junior Doctors’ Clinical Competence: A Feedback Loop', in Advances in Medical Education, Springer Netherlands, pp. 474 - 476, http://dx.doi.org/10.1007/978-94-011-4886-3_143

Journal articles

Bouckley T; Peiris D; Nambiar D; Prince S; Pearson SA; Schierhout G, 2025, '“I would be very proud to be part of an initiative that didn’t exclude people because it was hard”: mapping and contextualising health equity responsibilities and decision-making tensions in the implementation of a multi-level system reform initiative', International Journal for Equity in Health, 24, http://dx.doi.org/10.1186/s12939-025-02405-6

Bouckley T; Peiris D; Nambiar D; Mishra S; Sood T; Purwar P; Elshaug AG; Landon BE; Pearson SA; Huckel Schneider C; Schierhout G, 2025, 'Addressing health equity during design and implementation of health system reform initiatives: a scoping review and framework', International Journal for Equity in Health, 24, http://dx.doi.org/10.1186/s12939-025-02436-z

Tran DT; Cohen JM; Donald S; Cesta CE; Furu K; Parkin L; Pearson SA; Reutfors J; Robijn AL; Zoega H; Zwar N; Havard A, 2025, 'Risk of Major Congenital Malformations Following Prenatal Exposure to Smoking Cessation Medicines', JAMA Internal Medicine, 185, pp. 656 - 667, http://dx.doi.org/10.1001/jamainternmed.2025.0290

Ho CLB; Youens D; Abhayaratna WP; Bulsara MK; Hughes J; Moorin R; Pearson SA; Preen DB; Reid CM; Ruiter R; Saunders CM; Stricker BH; Stubbs J; van Rooij FJA; Wright C; Ha NT, 2025, 'Estimation of the Duration of Antihypertensive Prescriptions: Validation of a Data-Driven Approach Using Rotterdam Study Data', Pharmacoepidemiology and Drug Safety, 34, http://dx.doi.org/10.1002/pds.70164

Lin J; Milder TY; Deakin CT; de Oliveira Costa J; Havard A; Neuen BL; Buckley NA; Brieger D; Greenfield JR; Jun M; Day RO; Pearson SA; Falster MO, 2025, 'Trends in use of sodium-glucose cotransporter 2 inhibitors among people with type 2 diabetes following hospitalisation with heart failure: A population-based study', Diabetes Research and Clinical Practice, 224, pp. 112242, http://dx.doi.org/10.1016/j.diabres.2025.112242

Wilson BE; Wright K; Sengar M; Sullivan R; Pearson S-A; Barton MB; Gyawali B; De Vries E; Moja L; Pramesh CS; Booth CM, 2025, 'Analysis of 2023 World Health Organization cancer Essential Medicines List and concordance with resource stratified guidelines.', J Natl Cancer Inst, http://dx.doi.org/10.1093/jnci/djaf100

Tuesley KM; Spilsbury K; Pearson SA; Donovan P; Obermair A; Coory MD; Ali S; Pandeya N; Stewart L; Jordan SJ; Webb PM, 2025, 'Long-acting, progestin-based contraceptives and risk of breast, gynecological, and other cancers', Journal of the National Cancer Institute, 117, pp. 1046 - 1055, http://dx.doi.org/10.1093/jnci/djae282

Tillakeratne S; Valerio H; Alavi M; Hajarizadeh B; Martinello M; George J; Matthews G; Grebely J; Pearson SA; Dore GJ, 2025, 'Trends in cause-specific mortality among people with hepatitis C virus in New South Wales, Australia', International Journal of Drug Policy, 139, http://dx.doi.org/10.1016/j.drugpo.2025.104790

Deakin CT; Costa JDO; Brieger D; Lin J; Schaffer AL; Kidd M; Pearson SA; Falster MO, 2025, 'Post-discharge pharmacotherapy in people with atrial fibrillation hospitalized for acute myocardial infarction: an Australian cohort study 2018-22', European Heart Journal Quality of Care and Clinical Outcomes, 11, pp. 259 - 270, http://dx.doi.org/10.1093/ehjqcco/qcae068

Bruno C; Cesta CE; Hjellvik V; Ulrichsen SP; Bjørk MH; Esen BÖ; Gillies MB; Gissler M; Havard A; Karlstad Ø; Leinonen MK; Nørgaard M; Pearson SA; Reutfors J; Furu K; Cohen JM; Zoega H, 2025, 'Corrigendum to Antipsychotic use during pregnancy and risk of specific neurodevelopmental disorders and learning difficulties in children: a multinational cohort study [eClinicalMedicine 70 (2024) 102531/DOI: 10.1016/j.eclinm.2024.102531] (eClinicalMedicine (2024) 70, (S258953702400110X), (10.1016/j.eclinm.2024.102531))', Eclinicalmedicine, 81, http://dx.doi.org/10.1016/j.eclinm.2025.103139

Milder TY; Lin J; Pearson SA; de Oliveira Costa J; Neuen BL; Pollock C; Jun M; Greenfield JR; Day RO; Stocker SL; Brieger D; Falster MO, 2025, 'Discontinuation of SGLT2i in people with type 2 diabetes following hospitalisation for heart failure: A cause for concern?', Diabetes Obesity and Metabolism, 27, pp. 997 - 1000, http://dx.doi.org/10.1111/dom.16061

Crepalde-Ribeiro K; Braga MDG; Silveira MR; Moura AS; Vaz-de-Melo POS; Ferraz MMD; Pearson SA; Costa JDO, 2025, 'Non-adherence, discontinuation, and seroconversion among people on daily HIV pre-exposure prophylaxis (PrEP) in Brazil: a nationwide cohort study', AIDS Care Psychological and Socio Medical Aspects of AIDS HIV, 37, pp. 289 - 299, http://dx.doi.org/10.1080/09540121.2024.2443824

Råket HK; Milder T; Litchfield M; Jensen CB; Wang JN; Jimenez-Solem E; Petersen J; Pearson SA; Jaffe A; Falster MO, 2025, 'Reduced Use of Maintenance Therapies Among People With Cystic Fibrosis Following Initiation of Elexacaftor/Tezacaftor/Ivacaftor in Australia', Clinical Therapeutics, http://dx.doi.org/10.1016/j.clinthera.2025.05.016

Chidwick K; Bharat C; Gisev N; Havard A; Camacho X; Pearson SA; Degenhardt L, 2025, 'Trends in prescription opioid analgesic use in Australia from 2015 to 2022', International Journal of Drug Policy, 135, http://dx.doi.org/10.1016/j.drugpo.2024.104666

Milder TY; Lin J; Pearson SA; Greenfield JR; Day RO; Stocker SL; Neuen BL; Falster MO; de Oliveira Costa J, 2025, 'Use of, time to, and type of first add-on anti-hyperglycaemic therapy to metformin in Australia, 2018–2022', British Journal of Clinical Pharmacology, 91, pp. 117 - 126, http://dx.doi.org/10.1111/bcp.16231

de Oliveira Costa J; Lin J; Milder TY; Havard A; Greenfield JR; Day RO; Neuen BL; Gibson AA; Morton JI; Sacre JW; Pearson SA; Falster MO, 2025, 'Variation in uptake of sodium glucose cotransporter 2 inhibitors and glucagon-like peptide-1 receptor analogues in adults with type 2 diabetes at high cardiovascular risk', European Journal of Clinical Pharmacology, pp. 1 - 13, http://dx.doi.org/10.1007/s00228-025-03870-2

Yang O; Zhang Y; To YH; IJzerman MMJ; Liu J; Gibbs P; Trapani K; Pearson SA; Franchini F, 2024, 'Effects of clinical and socioeconomic factors on Medicare and patient costs for colorectal cancer in Australia: a retrospective multivariate regression analysis', BMJ Open, 14, http://dx.doi.org/10.1136/bmjopen-2023-081483

Schaffer AL; Buckley NA; Schumann J; Lim JS; Cairns R; Raubenheimer J; Pearson SA; Chitty K, 2024, 'Patterns of medicine use in the year prior to death by suicide: an Australian population-based case series study', Eclinicalmedicine, 77, http://dx.doi.org/10.1016/j.eclinm.2024.102858

Tillakeratne S; Pearson SA; Alavi M; Hajarizadeh B; Martinello M; Law M; George J; Amin J; Matthews G; Grebely J; Dore GJ; Valerio H, 2024, 'Trends in viral hepatitis liver-related morbidity and mortality in New South Wales, Australia', Lancet Regional Health Western Pacific, 51, http://dx.doi.org/10.1016/j.lanwpc.2024.101185

Gillies MB; Chidwick K; Bharat C; Camacho X; Currow D; Gisev N; Degenhardt L; Pearson SA, 2024, 'Long-term prescribed opioid use after hospitalization or emergency department presentation among opioid naïve adults (2014–2020)—A population-based descriptive cohort study', British Journal of Clinical Pharmacology, 90, pp. 2111 - 2123, http://dx.doi.org/10.1111/bcp.16093

Varney B; Brett J; Zoega H; Gillies MB; Powell M; Bateman BT; Shand AW; Pearson SA; Havard A, 2024, 'Opioid analgesic exposure during the first trimester of pregnancy and the risk of major congenital malformations in infants: a systematic review and meta-analysis†', Anaesthesia, 79, pp. 967 - 977, http://dx.doi.org/10.1111/anae.16307

Daniels B; Luckett T; Liauw W; Falster MO; Gisev N; Blyth FM; Pearson SA, 2024, 'Trajectories of Opioid Use Before and After Cancer Diagnosis: A Population-Based Cohort Study', Journal of Pain and Symptom Management, 68, pp. 282 - 291.e11, http://dx.doi.org/10.1016/j.jpainsymman.2024.06.006

Gerhardy L; Nassar N; Litchfield M; Kennedy D; Smith A; Gillies MB; Pearson SA; Zoega H; Shand A, 2024, 'Prescription retinoid and contraception use in women in Australia: A population-based study', Australasian Journal of Dermatology, 65, pp. 428 - 436, http://dx.doi.org/10.1111/ajd.14294

Zoega H; Falster M; Gillies M; Litchfield M; Camacho X; Bruno C; Daniels B; Donnolley N; Havard A; Schaffer A; Chambers G; Degenhardt L; Dobbins T; Gisev N; Ivers R; Jorm L; Liu B; Vajdic C; Pearson SA, 2024, 'The Medicines Intelligence Data Platform: A Population-Based Data Resource From New South Wales, Australia', Pharmacoepidemiology and Drug Safety, 33, http://dx.doi.org/10.1002/pds.5887

Tuesley KM; Spilsbury K; Webb PM; Pearson SA; Donovan P; Coory MD; Steer CB; Stewart LM; Pandeya N; Protani MM; Dixon-Suen S; Marquart-Wilson L; Jordan SJ, 2024, 'Use of an emulated trial to investigate the association between use of nitrogen-based bisphosphonates and risk of epithelial ovarian cancer', International Journal of Epidemiology, 53, http://dx.doi.org/10.1093/ije/dyae108

de Oliveira Costa J; Lin J; Milder TY; Greenfield JR; Day RO; Stocker SL; Neuen BL; Havard A; Pearson SA; Falster MO, 2024, 'Geographic variation in sodium-glucose cotransporter 2 inhibitor and glucagon-like peptide-1 receptor agonist use in people with type 2 diabetes in New South Wales, Australia', Diabetes Obesity and Metabolism, 26, pp. 2787 - 2795, http://dx.doi.org/10.1111/dom.15597

Lin J; De Oliveira Costa J; Pearson SA; Buckley NA; Brieger D; Schutte AE; Schaffer AL; Falster MO, 2024, 'Impact of coordinated care on adherence to antihypertensive medicines among adults experiencing polypharmacy in Australia', Journal of Hypertension, 42, pp. 1248 - 1255, http://dx.doi.org/10.1097/HJH.0000000000003721

Gillies MB; Camacho X; Bharat C; Buizen L; Blyth F; Currow D; Wilson A; Degenhardt L; Gisev N; Pearson SA, 2024, 'Oxycodone initiation in Australia (2014–2018): Sociodemographic factors and preceding health service use', British Journal of Clinical Pharmacology, 90, pp. 1656 - 1666, http://dx.doi.org/10.1111/bcp.16063

Robijn AL; Tran DT; Cohen JM; Donald S; Cesta CE; Furu K; Parkin L; Pearson SA; Reutfors J; Zoega H; Zwar N; Havard A, 2024, 'Smoking Cessation Pharmacotherapy Use in Pregnancy', JAMA Network Open, 7, http://dx.doi.org/10.1001/jamanetworkopen.2024.19245

Koch FC; Tang M; Walpola R; Aslam M; Pearson SA; Daniels B, 2024, 'Changes in systemic cancer therapy in Australia during the Delta and Omicron waves of the COVID-19 pandemic (2021–2022): a controlled interrupted time series analysis', Public Health Research and Practice, 34, http://dx.doi.org/10.17061/phrp34012402

Ali S; Coory M; Donovan P; Na R; Pandeya N; Pearson SA; Spilsbury K; Tuesley K; Jordan SJ; Neale RE, 2024, 'Predicting the risk of pancreatic cancer in women with new-onset diabetes mellitus', Journal of Gastroenterology and Hepatology Australia, 39, pp. 1057 - 1064, http://dx.doi.org/10.1111/jgh.16503

Camacho X; Schaffer AL; Brett J; Pratt N; Buckley NA; Henry D; Pearson SA, 2024, 'Quality use of publicly subsidised tapentadol in Australia: a population-based analysis', Internal Medicine Journal, 54, pp. 941 - 950, http://dx.doi.org/10.1111/imj.16335

Varney B; Zoega H; Gillies MB; Gisev N; Weston Shand A; Pearson SA; Havard A, 2024, 'Prevalence and Persistence of Prescription Opioid Use Following Hospital Discharge after Childbirth: An Australian Population-Based Cohort Study', Anesthesia and Analgesia, 138, pp. 970 - 979, http://dx.doi.org/10.1213/ANE.0000000000006582

Yu J; Arnott C; Li Q; Di Tanna GL; Tian M; Huang L; Yin X; Zhang X; Pearson SA; Labarthe DR; Elliott P; Yan LL; Zhou B; Wu Y; Neal B, 2024, 'Secondary Analysis of the Salt Substitute and Stroke Study (SSaSS): Effects of Potassium-Enriched Salt on Cardiac Outcomes', Hypertension, 81, pp. 1031 - 1040, http://dx.doi.org/10.1161/HYPERTENSIONAHA.123.22410

Tran DT; Falster MO; Pearse J; Mazevska D; McElduff P; Pearson S; van Gool KC; Hall J; Jorm L, 2024, 'The Australian Health Care Homes trial: quality of care and patient outcomes. A propensity score-matched cohort study', Medical Journal of Australia, 220, pp. 372 - 378, http://dx.doi.org/10.5694/mja2.52266

Hopkins RE; Bharat C; Buizen L; Close J; Ivers R; Draper B; Pearson SA; Degenhardt L; Gisev N, 2024, 'Age-Related Risk of Serious Fall Events and Opioid Analgesic Use', JAMA Internal Medicine, 184, pp. 394 - 401, http://dx.doi.org/10.1001/jamainternmed.2023.8154

Bruno C; Cesta CE; Hjellvik V; Ulrichsen SP; Bjørk MH; Esen BÖ; Gillies MB; Gissler M; Havard A; Karlstad Ø; Leinonen MK; Nørgaard M; Pearson SA; Reutfors J; Furu K; Cohen JM; Zoega H, 2024, 'Antipsychotic use during pregnancy and risk of specific neurodevelopmental disorders and learning difficulties in children: a multinational cohort study', Eclinicalmedicine, 70, http://dx.doi.org/10.1016/j.eclinm.2024.102531

Tran DT; Robijn AL; Varney B; Zoega H; Brew BK; Chambers GM; Falster K; Lingam R; Pearson SA; Havard A, 2024, 'Data Resource Profile: The Early Life Course data platform for research on perinatal and early childhood exposures and outcomes in Australia', International Journal of Epidemiology, 53, http://dx.doi.org/10.1093/ije/dyae045

Koch FC; Olivier J; Brett J; Buckley NA; Gisev N; Pearson S; Daniels B, 2024, 'The impact of tightened prescribing restrictions for PBS-subsidised opioid medicines and the introduction of half-pack sizes, Australia, 2020–21: an interrupted time series analysis', Medical Journal of Australia, 220, pp. 315 - 322, http://dx.doi.org/10.5694/mja2.52257

Stehlik P; Dowsett C; Camacho X; Falster MO; Lim R; Nasreen S; Pratt NL; Pearson SA; Henry D, 2024, 'Evolution of the data and methods in real-world COVID-19 vaccine effectiveness studies on mortality: a scoping review protocol', BMJ Open, 14, pp. e079071, http://dx.doi.org/10.1136/bmjopen-2023-079071

Jones AR; Currie D; Peng C; Ebeling PR; Center JR; Duque G; Lybrand S; Lyubomirsky G; Mitchell RJ; Pearson S; Seibel MJ; Occhipinti JA, 2024, 'Expanding access to fracture liaison services in Australia for people with minimal trauma fractures: a system dynamics modelling study', Medical Journal of Australia, 220, pp. 243 - 248, http://dx.doi.org/10.5694/mja2.52241

Ho C; Ha NT; Youens D; Abhayaratna WP; Bulsara MK; Hughes JD; Mishra G; Pearson SA; Preen DB; Reid CM; Ruiter R; Saunders CM; Stricker BH; van Rooij FJA; Wright C; Moorin R, 2024, 'Association between long-term use of calcium channel blockers (CCB) and the risk of breast cancer: a retrospective longitudinal observational study protocol', BMJ Open, 14, http://dx.doi.org/10.1136/bmjopen-2023-080982

Peiris D; Feyer AM; Barnard J; Billot L; Bouckley T; Campain A; Cordery D; de Souza A; Downey L; Elshaug AG; Ford B; Hanfy H; Hales L; Khalaj BH; Huckel Schneider C; Inglis J; Jan S; Jorm L; Landon B; Lujic S; Mulley J; Pearson SA; Schierhout G; Sivaprakash P; Stanton C; Stephens A; Willcox D, 2024, 'Overcoming silos in health care systems through meso-level organisations – a case study of health reforms in New South Wales, Australia', Lancet Regional Health Western Pacific, 44, http://dx.doi.org/10.1016/j.lanwpc.2024.101013

Lord SJ; Daniels B; O'Connell DL; Kiely BE; Beith J; Smith AL; Pearson SA; Chiew KL; Bulsara MK; Houssami N, 2024, 'Decline in the Incidence of Distant Recurrence of Breast Cancer: A Population-Based Health Record Linkage Study, Australia 2001-2016', Cancer Epidemiology Biomarkers and Prevention, 33, pp. 314 - 324, http://dx.doi.org/10.1158/1055-9965.EPI-23-0942

Neuen BL; Heerspink HJL; Vart P; Claggett BL; Fletcher RA; Arnott C; de Oliveira Costa J; Falster MO; Pearson SA; Mahaffey KW; Neal B; Agarwal R; Bakris G; Perkovic V; Solomon SD; Vaduganathan M, 2024, 'Estimated Lifetime Cardiovascular, Kidney, and Mortality Benefits of Combination Treatment With SGLT2 Inhibitors, GLP-1 Receptor Agonists, and Nonsteroidal MRA Compared With Conventional Care in Patients With Type 2 Diabetes and Albuminuria', Circulation, 149, pp. 450 - 462, http://dx.doi.org/10.1161/CIRCULATIONAHA.123.067584

Ali S; Coory M; Donovan P; Na R; Pandeya N; Pearson SA; Spilsbury K; Stewart LM; Thompson B; Tuesley K; Waterhouse M; Webb PM; Jordan SJ; Neale RE, 2024, 'Association between unstable diabetes mellitus and risk of pancreatic cancer', Pancreatology, 24, pp. 66 - 72, http://dx.doi.org/10.1016/j.pan.2023.11.009

Back to profile page